Current Class Action Lawsuits

Fen-Phen Progression Claim

Fen-Phen Progression Claims

Pondimin and Redux, diet drugs that contained Fen-Phen, were banned in 1997 after only one year of FDA approval.  People had been taking Fen-Phen throughout the 1990s, however, as an off-market drug.  That means it’s a drug not approved by the FDA.  Demand for such drugs is often so strong that the public overlooks lack of FDA approval and asks doctors for the product despite risks.  Fen-Phen held such promises in the 1990s that as many as 85,000 prescriptions a day were being written and filled.

Fen-Phen, the main ingredient in Pondimin and Redux, was finally approved by the FDA in 1996, but not by the chief medical officer, who refused to sign off.  Another medical officer approved the drug despite signs the drug was not safe.

Then in 1997 a doctor discovered that many of her patients on Fen-Phen developed pulmonary hypertension and heart-valve problems.  The diet drug was dangerous, even to those who took the drug for only one month. pulmonary hypertension and heart-valve abnormalities could also show up ten years after taking the drug.

A huge multi million dollar drug class action lawsuit was filed, and won by plaintiffs.  American Home Products, who manufactured Pondimin and Redux, was ordered to pay $3.75 billion in claims.  Now, Fen-Phen progression claims continue to this day.  A progression claim is when someone who registered with the original settlement, who had taken Fen-Phen, and who has developed more  or worse symptoms which may require additional settlement funds.  In other words, the situation has progressed and additional claims may be in order.

People who have taken Fen-Phen and who suffer deepening injuries, should act promptly to become part of a Fen-Phen progression claim.  Strict deadlines apply.